Back to Search
Start Over
Long-term Morbidity of Testicular Cancer Treatment
- Source :
- Urologic Clinics of North America. 42:393-408
- Publication Year :
- 2015
- Publisher :
- Elsevier BV, 2015.
-
Abstract
- Second malignant neoplasms, cardiovascular disease, neurotoxicity and ototoxicity, pulmonary complications, hypogonadism, and nephrotoxicity are potentially life-threatening long-term complications of testicular cancer and its therapy. This article describes the pathogenesis, risks, and management of these late effects experienced by long-term testicular cancer survivors, who are defined as individuals who are disease free 5 years or more after primary treatment. Testicular cancer survivors should follow applicable national guidelines for cancer screening and management of cardiovascular disease risk factors. In addition, health care providers should capitalize on the time of cancer diagnosis as a teachable moment to introduce and promote lifestyle changes.
- Subjects :
- Male
Oncology
medicine.medical_specialty
Teachable moment
Drug-Related Side Effects and Adverse Reactions
Urology
Antineoplastic Agents
Disease
Risk Assessment
Testicular Neoplasms
Quality of life
Internal medicine
Health care
Cancer screening
medicine
Humans
Survivors
Intensive care medicine
Life Style
Testicular cancer
business.industry
Hypogonadism
Cancer
Neoplasms, Second Primary
Neoplasms, Germ Cell and Embryonal
medicine.disease
Cardiovascular Diseases
Quality of Life
Kidney Diseases
Drug Monitoring
Nervous System Diseases
Risk assessment
business
Subjects
Details
- ISSN :
- 00940143
- Volume :
- 42
- Database :
- OpenAIRE
- Journal :
- Urologic Clinics of North America
- Accession number :
- edsair.doi.dedup.....242703bbbd4d9caa3c6f43e349151eb2